Clinical
Pharmacovigilance
Post-market monitoring of drug safety after regulatory approval.
Definition
Pharmacovigilance systems (e.g., FAERS in the U.S.) collect reports of adverse events after a drug reaches market, allowing detection of rare or long-latency safety signals.
Related terms
Back to the full peptide glossary.